Kinderhook’s PharMedQuest snags Long’s Drugs in $390 mln deal

New York's Tailwind will retain a minority equity stake in the specialty pharmacy company

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this